MEZAVANT Trademark

Trademark Overview

On Tuesday, August 18, 2015, a trademark application was filed for MEZAVANT with the United States Patent and Trademark Office. The USPTO has given the MEZAVANT trademark a serial number of 86728997. The federal status of this trademark filing is REGISTERED as of Tuesday, July 3, 2018. This trademark is owned by NOGRA PHARMA LIMITED. The MEZAVANT trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparation, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases
mezavant

General Information

Serial Number86728997
Word MarkMEZAVANT
Filing DateTuesday, August 18, 2015
Status700 - REGISTERED
Status DateTuesday, July 3, 2018
Registration Number5505720
Registration DateTuesday, July 3, 2018
Mark Drawing3000 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, April 17, 2018

Trademark Statements

Description of MarkThe mark consists of the stylized wording "MEZAVANT" in teal green with a white background. The second letter "A" in the wording includes a lime green circle in the center. A multi-circle loop design appears above the letters "AVAN" in lime green.
Goods and ServicesPharmaceutical preparation, namely, aminosalicylic acid in capsule, granule, tablet, suppository or enema forms suitable for the treatment of gastrointestinal diseases
Indication of Colors claimedThe color(s) teal green, lime green and white is/are claimed as a feature of the mark.

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, August 21, 2015
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameNOGRA PHARMA LIMITED
Party Type30 - Original Registrant
Legal Entity Type11 - Company
AddressDUBLIN 2
IE
Party NameNOGRA PHARMA LIMITED
Party Type20 - Owner at Publication
Legal Entity Type11 - Company
AddressDUBLIN 2
IE
Party NameNOGRA PHARMA LIMITED
Party Type10 - Original Applicant
Legal Entity Type11 - Company
AddressDUBLIN 2
IE

Trademark Events

Event DateEvent Description
Monday, July 3, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 3, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, April 17, 2018OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 17, 2018PUBLISHED FOR OPPOSITION
Wednesday, March 28, 2018NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, March 15, 2018NOTICE OF ALLOWANCE CANCELLED
Thursday, March 8, 2018ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
Friday, March 2, 2018NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, February 28, 2018SOU EXTENSION 3 GRANTED
Wednesday, February 28, 2018SOU EXTENSION 3 FILED
Wednesday, February 28, 2018TEAS EXTENSION RECEIVED
Friday, February 2, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, January 23, 2018TEAS POST PUBLICATION AMENDMENT RECEIVED
Monday, September 11, 2017PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
Thursday, September 7, 2017ASSIGNED TO PETITION STAFF
Friday, September 1, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, August 30, 2017SOU EXTENSION 2 GRANTED
Wednesday, August 30, 2017SOU EXTENSION 2 FILED
Wednesday, August 30, 2017TEAS EXTENSION RECEIVED
Monday, August 28, 2017TEAS PETITION TO AMEND BASIS RECEIVED
Thursday, March 2, 2017NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, February 28, 2017SOU EXTENSION 1 GRANTED
Tuesday, February 28, 2017SOU EXTENSION 1 FILED
Tuesday, February 28, 2017TEAS EXTENSION RECEIVED
Tuesday, August 30, 2016NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, July 5, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2016PUBLISHED FOR OPPOSITION
Wednesday, June 15, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Thursday, June 2, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, June 1, 2016TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, June 1, 2016CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, June 1, 2016TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, December 2, 2015NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION E-MAILED
Wednesday, December 2, 2015NON-FINAL ACTION WRITTEN
Wednesday, December 2, 2015ASSIGNED TO EXAMINER
Friday, August 21, 2015NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, August 21, 2015NEW APPLICATION ENTERED

Related Keywords

mezavant forms enema suitable treatment diseases gastrointestinal suppository tablet namely preparation